S
NAUT icon

SignatureFD’s Nautilus Biotechnolgy NAUT Stock Holding History

SignatureFD’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-37,313
Closed -$62.7K – 3404
2024
Q4 		$62.7K Hold
37,313
– – ﹤0.01% 1453
2024
Q3 		$106K Hold
37,313
– – ﹤0.01% 1184
2024
Q2 		$87.3K Hold
37,313
– – ﹤0.01% 1233
2024
Q1 		$110K Hold
37,313
– – ﹤0.01% 1132
2023
Q4 		$112K Hold
37,313
– – ﹤0.01% 1050
2023
Q3 		$118K Hold
37,313
– – ﹤0.01% 971
2023
Q2 		$144K Hold
37,313
– – ﹤0.01% 876
2023
Q1 		$103K Hold
37,313
– – ﹤0.01% 1024
2022
Q4 		$67.2K Hold
37,313
– – ﹤0.01% 1205
2022
Q3 		$79K Hold
37,313
– – ﹤0.01% 1074
2022
Q2 		$100K Hold
37,313
– – ﹤0.01% 986
2022
Q1 		$162K Hold
37,313
– – ﹤0.01% 814
2021
Q4 		$193K Buy
+37,313
New +$200K 0.01% 731

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

SignatureFD's NAUT Position: Q1 2025 in Review

SignatureFD sold out of Nautilus Biotechnolgy (NAUT) in Q1 2025, closing a stake of 37,313 shares — an estimated $62.7K sold.

SignatureFD first reported a position in NAUT in Q4 2021 and held it in 13 quarters. The position peaked at $193K in Q4 2021. 88 funds tracked by Wall St. Rank hold NAUT as of Q1 2025.

  • SignatureFD reported no remaining Nautilus Biotechnolgy position as of Q1 2025 after selling out during the quarter.
  • SignatureFD sold 37,313 Nautilus Biotechnolgy shares in Q1 2025, an estimated $62.7K.
  • SignatureFD first reported a position in Nautilus Biotechnolgy in Q4 2021 and held it in 13 quarters.
  • SignatureFD's Nautilus Biotechnolgy position peaked at $193K in Q4 2021.
  • 88 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2025.

Based on SignatureFD's 13F filing for Q1 2025, filed 2 May 2025.